Sign in

CIK 0001662579 · Non-accelerated filer<br>Smaller reporting company

C4 Therapeutics, Inc.

Sign in to watch
Ticker
CCCC
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
475617627
Phone
(617) 231-0700
Business address
490 ARSENAL WAY, SUITE 120, WATERTOWN, MA, 02472
  1. 4 Grant or award Director acquired 2,108 shares (grant or award)
  2. SC 13G Stake Amended Statement of Ownership
  3. SC 13G Stake Amended Statement of Ownership
  4. 8-K Event Regulation FD disclosure · Other events
  5. 8-K Event Material agreement · Regulation FD disclosure
  6. 4 Derivatives Options or other derivatives
  7. 3 Insider Initial Statement of Ownership
  8. 8-K Event Executive or director change · Regulation FD disclosure
  9. SC 13G Stake Amended Statement of Ownership
  10. 10-Q Report Quarterly Report
  11. 8-K Event Results of operations
  12. 4 Grant or award Director acquired 6,617 shares (grant or award)
  13. 4 Grant or award Director acquired 6,470 shares (grant or award)
  14. 4 Grant or award Director acquired 8,089 shares (grant or award)
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Grant or award Chief Financial Officer acquired 25,000 shares (grant or award)

Page 13 of 28 · 549 filings